Pliant Therapeutics PLRX Stock
Pliant Therapeutics Price Chart
Pliant Therapeutics PLRX Financial and Trading Overview
| Pliant Therapeutics stock price | 1.18 USD |
| Previous Close | 1.26 USD |
| Open | 1.26 USD |
| Bid | 0.9 USD x 200 |
| Ask | 1.56 USD x 200 |
| Day's Range | 1.2 - 1.26 USD |
| 52 Week Range | 1.09 - 1.95 USD |
| Volume | 756.01K USD |
| Avg. Volume | 494.7K USD |
| Market Cap | 74.3M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.83 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.67 USD |
PLRX Valuation Measures
| Enterprise Value | -67803704 USD |
| Trailing P/E | N/A |
| Forward P/E | -1.1705832 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.40691763 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.609 |
Trading Information
Pliant Therapeutics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -12.50% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 1.95 USD |
| 52 Week Low | 1.09 USD |
| 50-Day Moving Average | 1.25 USD |
| 200-Day Moving Average | 1.39 USD |
PLRX Share Statistics
| Avg. Volume (3 month) | 494.7K USD |
| Avg. Daily Volume (10-Days) | 556.9K USD |
| Shares Outstanding | 61.92M |
| Float | 60.23M |
| Short Ratio | 7.26 |
| % Held by Insiders | 2.34% |
| % Held by Institutions | 81.94% |
| Shares Short | 3.44M |
| Short % of Float | 5.69% |
| Short % of Shares Outstanding | 5.55% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -25.78% |
| Return on Equity (ttm) | -53.61% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -111398000 USD |
| Net Income Avi to Common (ttm) | -113218000 USD |
| Diluted EPS (ttm) | -1.83 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 170.89M USD |
| Total Cash Per Share (mrq) | 2.76 USD |
| Total Debt (mrq) | 28.78M USD |
| Total Debt/Equity (mrq) | 17.43 USD |
| Current Ratio (mrq) | 16.887 |
| Book Value Per Share (mrq) | 2.949 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -98701000 USD |
| Levered Free Cash Flow (ttm) | -61810124 USD |
Profile of Pliant Therapeutics
| Country | United States |
| State | CA |
| City | South San Francisco |
| Address | 331 Oyster Point Boulevard |
| ZIP | 94080 |
| Phone | 650 481 6770 |
| Website | https://pliantrx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 49 |
Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company's lead product candidate is the PLN-101095, an oral, small molecule dual inhibitor of avß8 and avß1 integrins that is in Phase 1a/1b for the treatment of solid tumors. It is also developing drug discovery platform comprising proprietary library of over 15,000 integrin binding molecules, focusing on integrin-based target-mediated drug delivery. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Q&A For Pliant Therapeutics Stock
What is a current PLRX stock price?
Pliant Therapeutics PLRX stock price today per share is 1.18 USD.
How to purchase Pliant Therapeutics stock?
You can buy PLRX shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pliant Therapeutics?
The stock symbol or ticker of Pliant Therapeutics is PLRX.
Which industry does the Pliant Therapeutics company belong to?
The Pliant Therapeutics industry is Biotechnology.
How many shares does Pliant Therapeutics have in circulation?
The max supply of Pliant Therapeutics shares is 61.92M.
What is Pliant Therapeutics Price to Earnings Ratio (PE Ratio)?
Pliant Therapeutics PE Ratio is now.
What was Pliant Therapeutics earnings per share over the trailing 12 months (TTM)?
Pliant Therapeutics EPS is -1.83 USD over the trailing 12 months.
Which sector does the Pliant Therapeutics company belong to?
The Pliant Therapeutics sector is Healthcare.
Pliant Therapeutics PLRX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Global Select Market Com NQGS | 13180.97 USD — |
-0.87
|
— — | 13139.79 USD — | 13316.81 USD — | — - | — — |
| Stlmt ID US Tech Biotechnology NBX | 3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| US Tech US 700 Small Cap Index NQUS700SC | 2992.49 USD — |
-1.38
|
— — | 2986.86 USD — | 3018.97 USD — | — - | — — |
| US Tech AlphaDEX Multi Cap Growt NQDXUSMLTCG | 4054.02 USD — |
-0.25
|
— — | 4019.75 USD — | 4077 USD — | — - | — — |
| US Tech Biotechnology NBI | 5807.22 USD — |
+1.87
|
— — | 5685.34 USD — | 5809.82 USD — | — - | — — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
- {{ link.label }} {{link}}